CC Small or few human trials. Promising, not proven. How we grade →Clinical practice guideline · Task force consensus with systematic reviews
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
MF Holick, NC Binkley, HA Bischoff-Ferrari, CM Gordon, DA Hanley, RP Heaney et al. The Journal of Clinical Endocrinology & Metabolism. 2011.
- In plain language
- Suggested 25(OH)D testing for people at risk of deficiency, not screening of people who are not at risk.
- Limits
- Largely superseded for prevention questions by the 2024 guideline.
- Which of our grades it feeds
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Science summary: Vitamin D testing and dose: what your 25(OH)D number means, how much D3 moves it, and why more is not better
- Source
- doi.org/10.1210/jc.2011-0385 · PubMed 21646368
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.